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DNA Methylation 
• DNA methylation in the mammalian genome refers to the methylation 
of cytosine (5-methyl-cytosine, m5C) within a CpG dinucleotide. 
•  CpG is a palindromic sequence, and typically the cytosines in both 
strands are methylated.  
• It is estimated that approximately 80% of C residues within CpG 
dinucleotides are methylated.  
• As m5C can undergo spontaneous deamination to thymine, 
methylated CpG dinucleotides are hot spots for mutation and are 
slowly eliminated during evolution. Therefore, in large parts of the 
mammalian genome, CpG dinucleotides occur at a much lower 
frequency than expected from the relative frequency of C and G 
residues. 
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 Several techniques have been developed to determine DNA 
methylation patterns. The gold standard is the sequencing of 
sodium bisulfite-treated  genomic DNA . Sodium bisulfite converts 
C, but not m5C, into uracil. During PCR, thymine replaces uracil. 
The PCR products are then sequenced directly or after subcloning 
into a plasmid vector. The presence of a CpG dinucleotide in the 
final sequence indicates that the cytosine residue was originally 
methylated. A TpG dinucleotide that is not present in the untreated 
DNA indicates the presence of an unmethylated cytosine in the 
genomic DNA. 
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DNA Methyltransferases 
• Three active DNA methyltransferases have been identified in 
human cells: DNMT1, DNMT3A, and DNMT3B. In addition, there 
is one putative DNA methyltransferase (DNMT2) and a protein 
that is highly similar to DNMT3A and B, but devoid of catalytic 
activity (DNMT3L). All methyltransferases use   S -adenosyl-
methionine as a methyl donor. 
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DNMT1 
• It is ubiquitously expressed and is a maintenance 
methyltransferase, which methylates hemi-methylated CpG 
dinucleotides in the nascent DNA strand after replication. It is 
essential for maintaining DNA methylation patterns in 
proliferating cells. 
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• DNMT3A and DNMT3B are regulated during development. 
They carry out de novo methylation and thus establish new 
DNA methylation patterns.  
• DNMT3L cooperates with DNMT3A and DNMT3B to establish 
methylation imprints.  
• The activity and function of DNMT2 remains undefined. 
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Methyl-Cytosine-Binding Proteins 
• Mammalian cells contain several proteins that bind to single 
m5Cs or clusters of neighboring m5Cs. 
 
• MECP2: contains a methyl-CpG-binding domain (MBD) and a 
transcription repression domain (TRD). 
• MBD1 
• MBD2 
MECP2, MBD1, and MBD2 function as transcription repressors. 
• MBD3 
• MBD4: a DNA glycolase and is involved in DNA mismatch repair. 
• KAISO: lacks an MBD domain and binds methylated CGCG through its 
zinc-finger domain. 7 
Genomic Imprinting  
• In placental mammals (eutheria) aproximately 100 
genes are expressed from either the paternal or the 
maternal allele only. These genes are subject to 
genomic imprinting, which is an epigenetic process by 
which the male and the female germline each confer a 
sex-specific mark (imprint) on certain chromosomal 
regions.  
• As a consequence, the paternal and the maternal 
genome are functionally nonequivalent and both are 
required for normal embryonic development. 
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              Genomic imprinting 
• Genomic imprinting is a genetic phenomenon by which certain genes 
are expressed in a parent-of-origin-specific manner. It is an inheritance 
process independent of the classical Mendelian inheritance. Imprinted 
alleles are silenced such that the genes are either expressed only from 
the non-imprinted allele inherited from the mother (e.g. H19 or 
CDKN1C), or in other instances from the non-imprinted allele inherited 
from the father (e.g. IGF-2). Forms of genomic imprinting have been 
demonstrated in insects, mammals and flowering plants. 
• Genomic imprinting is an epigenetic process that involves methylation 
and histone modifications in order to achieve monoallelic gene 
expression without altering the genetic sequence. These epigenetic 
marks are established in the germline and are maintained throughout 
all somatic cells of an organism. 
• Appropriate expression of imprinted genes is important for normal 
development, with numerous genetic diseases associated with 
imprinting defects including Beckwith–Wiedemann syndrome, Silver–
Russell syndrome, Angelman syndrome and Prader–Willi syndrome. 
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•  Imprinted genes are not randomly distributed in the genome, 
but tend to occur in clusters. In humans, imprinted gene 
clusters have been found on chromosomes 6, 7, 11, 14, and 
15. The clustering of imprinted genes suggests that the primary 
control of imprinting is not at the single gene level, but at the 
chromosome domain level. 
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Prader-Willi Syndrome (PWS) Angelman Syndrome (AS) 
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PWS vs AS 
• del 15 q11-13 
 
   del 15 P        PWS 
   del 15 M        AS 
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• The proximal long arm of human chromosome 15 (15q11-
q13) contains a cluster of imprinted genes which are affected 
in the Prader–Willi syndrome (PWS) and the Angelman 
syndrome. 
•  Paternal-only expression of   MKRN3 ,    NDN ,    SNRPN , 
and (possibly)   MAGEL2  is associated with differential DNA 
methylation. Whereas the promoter/exon 1 regions of these 
genes are unmethylated on the expressing paternal 
chromosome, the silent maternal alleles are methylated. In 
addition to DNA methylation, the parental copies of these 
genes also differ in histone modification.  
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The    SNRPN  gene encodes two proteins, SNURF and SNRPN, serves as a 
host for 79 C/D small nucleolar (sno) RNA genes, and overlaps, in an 
antisense orientation, the   UBE3A  gene. The snoRNAs are encoded within 
introns of the   SNRPN  gene. They are expressed from the paternal allele 
only, because they are processed from the paternally expressed   SNRPN   
sense/  UBE3A  antisense transcript during the splice process. Thus, imprinted 
expression of the snoRNAs is indirectly regulated through SNRPN  
methylation. Unlike other C/D box snoRNAs, the snoRNAs encoded within the   
SNRPN  locus do not serve a guide RNAs for 2’-O-ribose methylation of 
nucleotides in rRNA. Their function remains to be determined.  
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PWS 
• A ~4-Mb de novo interstitial deletion of the paternal 
chromosome 15 [del(15)(q11-q13)pat], which includes the 
entire imprinted domain plus several nonimprinted genes, is 
found in the majority (~70%) of patients with PWS.  
• The second most common genetic abnormality in PWS (~30%) 
is a maternal uniparental disomy 15 [upd(15)mat], which most 
often arises from maternal meiotic nondisjunction followed by 
mitotic loss of the paternal chromosome 15 after fertilization. A 
few patients with PWS have apparently normal chromosomes 
15 of biparental inheritance, but the paternal chromosome 
carries a maternal imprint (imprinting defect).  
20 
AS 
• In contrast to the paternally active genes, the maternally active   
UBE3A  gene lacks differential DNA methylation. Another striking 
difference is that imprinted UBE3A  expression is tissue-specific. At 
present it is unclear how tissue-specific imprinting of UBE3A is 
regulated, but the paternally expressed   SNRPN  sense/  UBE3A  
antisense transcript may be involved in silencing the paternal   UBE3A   
allele.  
•  The loss of function of the   UBE3A  gene leads to AS. Similar to 
PWS, the major lesion in AS is a common large deletion of 15q11-q13 
(~70%), but in AS the deletion is on the maternal chromosome. AS 
can also result from upd(15)pat (~1% of cases), which most often 
arises from the postzygotic duplication of a zygote carrying only a 
paternal chromosome 15, or the lack of a maternal imprint on the 
maternal chromosome (imprinting defect; ~4% of cases). 
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BWS 
• Another cluster of imprinted genes with relevance to human disease is 
located on 11p15.5. It is affected in patients with Beckwith–
Wiedemann syndrome (BWS) and some patients with Silver-Russell 
syndrome (SRS).  
• BWS is caused by overexpression of the paternally active  IGF2   gene 
and silencing of the maternally expressed   H19  gene or by silencing 
or mutational inactivation of the maternally active   CDKN1C  gene. 
These genes map to the short arm of chromosome 11, but are 
controlled by two different ICs,   IGF2/H19  IC (IC1), and   
LIT1/KCNQ1OT1 (IC2), which controls imprinting of   CDKN1C .  
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Epigenetic  diseases 
 
24 
X-inactivation  
( Lyon hypothesis ) 
Barr body 
• Small, darkly staining bodies were 
described by Barr & Bertram in 1949 
in the nerve cells of female cats , but 
not in males.  
• Davidson & Smith described similar 
structures as drum-sticks in 
peripheral blood leukocytes. 
• Mary F. Lyon in 1961 described a 
mosaic distribution pattern of X-linked 
coat colors in female mice as a 
manifestation of X inactivation 
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     1. Dosage compensation  
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        Mechanism of X-inactivation 
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• X inactivation is initiated at a master control locus in Xq13, the X 
inactivation center (Xic). The Xic is also involved in “counting,” by 
which the cell recognizes whether it has one, two, or more X 
chromosomes, and “choice,” by which the cell determines which X 
will remain active. Any supernumerary X chromosome will be 
inactivated. 
• The Xic harbors the Xist gene (X-inactive specific transcript), which 
is required for the initiation of X inactivation. The gene encodes a 
17-kb untranslated RNA. The RNA is transcribed from and coats the 
X chromosome that has been selected to become inactivated. 
• Within one or two cell cycles gene silencing occurs along the length 
of this chromosome. The association of Xist RNA with chromatin is 
mediated by sequences that are functionally redundant and 
dispersed throughout the transcript. The silencing requires a 
conserved region at the 5’ end. After the initiation of silencing, Xist 
becomes dispensable. 
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• The X-chromosomal genes are inactivated by extensive histone 
modifications:  
• Hypoacetylation of H3 and H4 
• Dimethylation of H3K9 
• Trimethylation of H3K27 
• Hypomethylation of H3K9 
 
• Polycomb group proteins and associated chromatin-modifying enzymes 
(Eed and Enx1, the latter being a H3K9 and K27 HMT) are mediators of 
the transition from the reversible inactive, Xist-dependent phase of 
inactivation, to the irreversible, Xist-independent phase. Later, the 
incorporation of the histone variant macroH2A and DNA methylation play 
an important part in maintaining the inactive state. 29 
2. Escape from 
 X-inactivation 
• A fraction of the genes along the X chromosome escape 
inactivation on the Xi. The Xist gene is expressed at high levels 
on the Xi and is not expressed on the Xa. Other genes are 
expressed equally from the Xa and Xi; mice contain few genes 
which escape silencing whereas up to a quarter of human X 
chromosome genes are expressed from the Xi. Many of these 
genes occur in clusters. 
• Genes in defined regions of the human X chromosome are not 
activated. An X-inactivation profile (Carrel &Willard, 2005) reveals 
that 458 (75%) genes are inactivated and 94 (15%) regularly 
escape inactivation. Surprisingly, 65 genes (10%) are inactivated 
in some females, but not in others. Thus, 25% of X-linked human 
genes are not regularly inactivated, and 10% exhibit an 
interindividual inactivation pattern. 
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X inactivation skewing 
• 3. Variable expressivity of X-linked genes in 
heterozygotes  
 
• 4. Manifesting heterozygotes 
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5. Mosaicism 
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Review 
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